Cooperative Agreement NH25PS005222

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...

Federal Project Grant Award Summary The John E. Fogarty International Center awarded Partnership For Research And Action For Health a $192,292 Project Grant (CFDA 93.989: International Research and Research Training) effective April 1, 2026 through March 31, 2029 to reduce HIV-related stigma and enhance prevention among men who have sex with men (MSM) in Georgia. The award funds the adaptation and pilot testing of evidence-based digital health interventions—specifically video content and...

Equitas Health Inc. received $414,129 in obligated federal funding under the HIV-Related Training and Technical Assistance program (CFDA 93.145), administered by the Health Resources and Services Administration's HIV/AIDS Bureau. The award, effective September 1, 2025, through August 31, 2026, supports the development and implementation of a mobile dental clinic infrastructure in Columbus, Ohio, to expand oral healthcare access for people living with HIV (PLWH). The $138,043 capacity development...

Bedford Stuyvesant Family Health Center Inc. (BSFHC) received a $300,000 Project Grant award from the Health Resources and Services Administration's HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the Ryan White HIV/AIDS Program Part C Capacity Development Program. The award, effective September 1, 2025, through August 31, 2026, supports HIV Care Innovation initiatives designed to enhance BSFHC's organizational capacity to deliver high-quality...

Summary: EFHISA Project Grant Award The Safe Blood For Africa Foundation received $156,179 in funding from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989) to conduct the Effect of HIV Infection on Sickle Cell Disease Outcomes (EFHISA) study. Awarded on June 1, 2026, with completion targeted for May 31, 2028, this project will establish a clinical registry of sickle cell disease (SCD) patients in Cameroon to address critical...

Community Health Center, Incorporated (CHCI) received a $230,768 Project Grant award from the Health Resources and Services Administration's HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) for the period of September 1, 2025 through August 31, 2026. Under the HIV Care Innovations category, CHCI will develop integrated systems of care that address the critical gap between HIV and substance use disorder (SUD) services for vulnerable populations. The...

Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Cooperative Agreement valued at $13.255 million to Harvard T.H. Chan School of Public Health on September 12, 2025, to conduct the Pediatric HIV/AIDS Cohort Study (PHACS): Research on Immune Aging, Sexual and Reproductive Health, and Perinatal Acquisition: Elucidating Relationships in HIV (RISE) program through August 31, 2030. Although listed under the Oral Diseases and Disorders Research program (CFDA...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

The Geisinger Clinic received a $123,809 cooperative agreement award from the Department of Health and Human Services Office of the Secretary Office of the National Coordinator for Health Information Technology under the Strengthening the Technical Advancement & Readiness of Public Health via Health Information Exchange Program (STAPH HIE Program, CFDA #93.462) for the period of January 14, 2021 through January 13, 2022. The STAPH HIE Program aims to strengthen and expand the ability of...

Cornell Scott Hill Health Corporation received a $617,648 Project Grant award from the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau under the Special Projects of National Significance (SPNS) program (CFDA 93.928), effective August 1, 2025, through July 31, 2029. As a demonstration/implementation site, Cornell Scott Hill Health Corporation will develop and implement innovative models of HIV care and treatment designed to address emerging needs of Ryan White HIV/AIDS Program...